Three-Year Outcomes after CTA with 2-Stent Technique Vs. Provisional Stenting for Complex Bifurcation Lesions

The prevalence of coronary lesions with bifurcation involvement is about 20% in patients undergoing coronary angiography (CTA). While provisional stenting is overall the most accepted technique, the 2018 myocardial revascularization guidelines recommend the 2-stent technique for complex bifurcation lesions, defined as side branch with lesion >5mm, distal reference diameter of the side branch ≥2.75, or difficulty in accessing the side branch prior stent implantation in the main vessel. 

Resultado a 3 años luego de ATC con técnica de 2- stents vs Provisional stent por bifurcaciones complejas

Prospective, multicenter, randomized study DEFINITION II reported a significant improvement in clinical outcomes after one year using the 2-stent technique in patients with complex coronary bifurcation lesions. However, there is no long-term information on the benefit of these techniques.

The purpose of this study was to evaluate the 3-year follow-up clinical outcomes after the 2-stent technique vs. provisional stenting.

The primary endpoint (PEP) was treated lesion failure (TLF), which included cardiovascular death, treated-vessel-related acute myocardial infarction (AMI), and clinically driven repeat vascularization of the treated vessel (TVF). The safety endpoint was stent thrombosis.

The study enrolled 635 patients, 328 in the 2-stent arm and 325 in the provisional stenting (PS) arm. Mean patient age was 63 years old, and most subjects were male. Of all patients, 34% had diabetes, and the most frequent clinical presentation was unstable angina. 

In the PS arm, 22% of patients needed a side branch stent due to suboptimal outcomes. Furthermore, side branch pre-treatment increased the need for additional stent use in the PS arm (32% vs. 14%, p < 0,001). There were no differences between arms in POT and kissing balloon use. The intravascular ultrasound (IVUS) use rate was 27%.

Read also: Same Day Discharge in NSTE-ACS: Is It Possible?

The 3-year PEP was 16% in the PS arm and 10% in the 2-stent arm (hazard ratio [HR]: 0.63; 95% confidence interval [CI]: 0.41-0.97; p = 0.035). There was a predominance of increased AMI (8.0% vs. 3.7%; HR: 0.63; 95% CI: 0.41-0.97; p =0.035) and treated vessel revascularization (HR: 0.50; 95% CI: 0.26-0.96; p = 0.038) in the PS arm. There was no difference in the safety endpoint between the two arms.

Among patients in the PS arm, patients requiring 2 stents had higher TLF rates, which was attributed to the high rate of repeat revascularization. Finally, patients who experienced intraprocedural complications had a higher rate of TLF at 1 year compared with patients with no complications.

Conclusion

The risk of future events remains present for patients with complex coronary bifurcation lesions with no events 1 year after the procedure.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: 3-Year Outcomes After 2-Stent With Provisional Stenting for Complex Bifurcation Lesions Defined by DEFINITION Criteria.

Reference: Jing Kan, MBBS et alJ Am Coll Cardiol Intv 2022;15:1310–1320.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...